Topical Hair Loss Treatments Market 2018

Minoxidil Market Report 2017

United States Minoxidil Market Report 2017 : by applications, including Alopecia, Hair Loss Treatment, Hair Replacement Surgery and Chemotherapy, Forecast to 2022

Research N Reports has proclaimed the addition of a new market intelligence report, titled “United States Minoxidil Market Report 2017.” The report provides key statistics on the market status, present situation & future forecast of United States Minoxidil Market industry.

Minoxidil Market measure development will be driven by the general interest for balding treatment. Widening little veins and permitting hair regrowth by improving cell prosaisms are key elements for this item, an alluring hair regrowing pharmaceutical among men and ladies.

Riotous way of life, change in dietary patterns, rising feeling of anxiety and hormonal changes are capable elements for balding. United States alopecia (hair loss treatment) market was esteemed at more than USD XX billion of every 2016, which hopes to surpass USD XX billion income by 2022.

Endorsement from FDA to be sold the pharmaceutical without medicine over the counter for men and ladies makes the item more agreeable in the market.

Market Elements:

The United States Minoxidil market research report will assist you take well-versed decisions, understand opportunities, plan effective business strategies, plan new projects, analyze drivers and restraints and give you a vision on the industry forecast.

Report by material, application, and geography – United States prospect to 2022 is an expert and extensive research report on the United States major regional market conditions, focusing on the main regions (The West, Southwest, The Middle Atlantic, New England, The South and The Midwest).

This report focuses also on consumption, market share and growth rate of Minoxidil Market in each application, can be divided into various Applications.

The United States Minoxidil market applications/end users wise and product category wise examination. On the basis of end users / applications, this report focuses on the status and outlook for major applications/end users, sales volume, and market share and growth rate of the United States market for each application.

Significant Drivers and Limitations:

Key Players profiled in the “United States Minoxidil Market” Report include McNeil Consumer Healthcare, Changland Technology, Proderma SRL, Pharhome International, Metapharmaceutical, Suzhou Habourbiotech, Carnosine, Darkar Holdings, Loy Pharma Lab. It also provides essential information about leading companies, such as product specification, financial overview, business overview, contact information, and recent developments.

minoxidil market report

The challenges faced by the companies, the factors helping them to reach the top level in the United States Minoxidil market, and the strategies implemented by each of the market players to market their products have been given. With the help of such data, a stakeholder or an emerging player in the market is armed to make strategic decisions leading to their benefit or profit.

The research report profiles the players and offers a detailed report about the competitive landscape present in the United States Minoxidil market. Additionally, the report also includes overall analysis. The report also discusses the business and marketing strategies likely to be implemented by these in the coming few years.

Table of Contents:

Minoxidil Market Research 2017

  • Minoxidil Market Overview
  • Minoxidil Segment by Application, Type, Region
  • United States Minoxidil Market Competition by Manufacturers
  • United States Minoxidil Production, Revenue (Value) by Region (2012-2017)
  • United States Minoxidil Supply (Production), Consumption, Export, Import by Regions
  • United States Minoxidil Manufacturers Profiles/Analysis
  • Marketing Strategy Analysis, Distributors/Traders
  • Market Effect Factors Analysis
  • United States Minoxidil Market Forecast (2017-2022)
  • Research Findings and Conclusion

Purchase full report with Discount @

About Research N Reports:

Research N Reports spends significant time in industry analysis, advertise figures and therefore getting quality reports covering all verticals, regardless of whether be it gaining point of view on current economic situations or being ahead in the merciless Global competition.

Since we exceed expectations at business research to enable businesses to develop, we additionally offer consulting as an extended arm to our administrations which only causes us gain more insight into current trends and issues.


Capillus® Introduces 5% Extra Strength Minoxidil For Men To Product Lineup

Capillus® Introduces 5% Extra Strength Minoxidil For Men To Product Lineup

Capillus®, LLC, a medical device manufacturer focused on providing customers with the best products in treatment for hair loss, announced today the addition of 5% Extra Strength Minoxidil Hair Regrowth Treatment for men to its product lineup.

The hair regrowth treatment revitalizes hair follicles and is clinically proven to help regrow hair in men.

The topical, liquid solution uses a precision spray applicator, which allows for a more targeted application than other similar products in the market.

This hands-free application method ensures that more of the formula actually reaches the scalp, resulting in higher absorption.

It is also a cleaner method of application and dries more quickly compared to other treatments.

5% Extra Strength Minoxidil Hair Regrowth Treatment

“We are thrilled to now be able to offer Minoxidil for Men,” said Carlos Pina, chief executive officer, Capillus, LLC. “We are continually looking at ways to improve the lives of hair loss sufferers, and are excited to provide our patient community yet another option for treatment.”

The hair regrowth treatment is indicated to treat thinning hair or gradual hair loss on the top of the scalp. It is not intended for frontal baldness or a receding hairline.

5% Extra Strength Minoxidil Hair Regrowth Treatment joins Capillus’ line of medical laser devices (Capillus82, Capillus202, Capillus272 Pro, & Capillus272 OfficePro) and cosmetic products, which include a line of clinical hair care products and keratin hair fibers.

5% Extra Strength Minoxidil Hair Regrowth Treatment (MSRP $17.99) is available for purchase on


Capillus, LLC is a Miami-based medical device manufacturer & marketer of solutions for hair loss. Founded in 2012, the company is a resource for those battling hair loss. Capillus, LLC serves the physician and the consumer market with medical laser devices (Capillus82, Capillus202, Capillus272 Pro, & Capillus272 OfficePro) and cosmetic products which include a line of clinical hair care products and keratin hair fibers. The company also connects patients to hair transplant surgeons & dermatologists for both surgical & non-invasive treatment options.

Capillus was founded in October 2012 and received its first FDA 510(k) clearance in January of 2015.  Capillus has been manufacturing its medical laser devices since January 2015. The company moved to its present day 25,000 square foot location in the area of Doral to expand its manufacturing facilities in June of 2015 and has been experiencing steady growth with a total of 7 FDA 510(k) clearances for its seven laser therapy models.

Building on its mission to provide customers with the best products in treatment of hair loss, all Capillus products cater to both women & men with thinning hair or at risk for thinning hair, a condition that affects up to 50% of adult women & 80% of adult men.